Trimetazidine ameliorates the hepatic injury associated with ischaemia-reperfusion in rats

Pharmacological Research

Volumn 39, Issue 3, 1999, Pages 211-216

  Settaf, Abdellatif ^a   Morin, Didier ^b   Lamchouri, Fatima ^a   Elimadi, Aziz ^b   Cherrah, Yahia ^a   Tillement, Jean Paul ^b  

^a Faculté de Médecine   (Morocco)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

ATP; Ischaemia reperfusion; Protective effect; Rat liver; Trimetazidine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORONARY VASODILATING AGENT; TRIMETAZIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER FUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0033105274     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0427     Document Type: Article

References (30)

1. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg 1989; 1: 13-19.
2. Bismuth H. The need for a consensus agreement on indications of liver transplantation. Hepatology 1994; 20: 1S-2S.
3. Numes G, Blaisdell F, Margaretten N. Mechanism of hepatic dysfunction following shock and trauma. Arch Surg 1970; 100: 546-56.
4. Kurokawa T, Nonami T, Harada A, Nakao A, Takagi H. Mechanisms and prevention of ischemia-reperfusion injury of the liver. Semin Surg Oncol 1996, 12: 179-82.
5. Rauen U, Viebahn R, Lauchard W, De Groot H. The potential role of reactive oxygen species in liver ischemia/reperfusion injury following liver surgery. Hepatogastroenterology 1994; 41: 333-6.
6. Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994; 19: 118-21.
7. Okuaki Y, Miyazaki H, Zeniya M, Ishikawa Y, Ohkawa Y, Tsuno S, Sakagushi M, Hara M, TakaHashi H, Toda G. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 1996; 16: 188-94.
8. Kamiike W, Watanabe F, Hashimoto T, Tagawa K, Ikeda Y, Nakao K, Kawashima Y. Changes in cellular level of ATP and its catabolites in ischemic rat liver. J Biochem 1982; 91: 1349-56.
9. Gunter TE, Gunter KK, Sheu SS, Gavin CE. Mitochondrial calcium transport: Physiological and pathological relevance. Am J Physiol 1994; 267: C313-19.
10. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
11. Metzger J, Lauterburg BH. Postischemic ATP levels predict hepatic function 24 hours following ischemia in the rat. Experientia 1988; 44: 455-7.
12. Lavanchy N, Martin J, Rossi A. Anti-ischemic effect of trimetazidine: 31-P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn 1987; 286: 97-110.
13. Guarnieri C, Muscari C. Effect of trimetazidine on mitochondrial functions and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 1993; 46: 324-31.
14. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxie and reoxygenation. J Mol Cell Cardiol 1994; 26: 949-58.
15. Hauet T, Mothes D, Goujon JM, Caritez JC, Carretier M, Le Moyec L, Eugene M, Tillement JP. Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischemia. Transplantation 1997; 64: 1082-6.
16. Nauta RJ, Uribe M, Walsh DH, Butterfield A. Description of a chronic in vivo model for the study of warm hepatic ischemia/reperfusion injury. Surg Res Commun 1989; 6: 241-6.
17. Jaworec D, Greber W, Bergmeyer HV. Adenosine 5′ triphosphate. In: Methods of Enzymatic Analysis. Bergmeyer HV, ed. 2nd ed. New York: Academic Press, 1974; 4: 2097-101.
18. Harpey C, Clauser P, Labrid C, Freyria JL, Poirier JP. Trimetazidine, a cellular anti-ischemic agent. Cardiovasc Drugs Rev 1988; 4: 292-312.
19. Sellier P, Audoin P, Rayen B, Corona P, Duong TC, Ourbak P. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 1987; 33: 205-7.
20. Xia ZF, Horton JW, Zhao PY, Babcock EE, Sherry AD, Malloy CR. Effects of ischemia on intracellular sodium and phosphates in the in vivo rat liver. J Appl Physiol 1996; 81: 1395-403.
21. Kurokawa T, Kobayashi H, Nonami T, Harada A, Nakao A, Takagi H. Mitochondrial gluthatione redox and energy producing function during liver ischemia and reperfusion. J Surg Res 1996; 66: 1-5.
22. Guarnieri C, Muscari C. Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats. Biochem Pharmacol 1988; 37: 4685-8.
23. 2+ and heart function after ischemia. Am J Physiol 1980; 232: H909-H916.
24. Wait R, White G, Davis T. Beneficial effect of verapamil on postischemic renal failure. Surgery 1983; 94: 276-82.
25. Sakr MF, Zetti GM, Hassanein TI, Farghali H, Nalesnik MA, Gavader JS, Starzl TE, Van Thiel DH. FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991; 13: 947-51.
26. Dhar DK, Takemoto Y, Nagasue N, Uchida M, Ono T, Nakamura T. FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. J Surg Res 1996; 60: 142-6.
27. Sewerynek E, Reiter RJ, Melchiori D, Ortiz GG, Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: Protection by melatonin. Hepato-gastroenterology 1996; 43: 898-905.
28. Nishizawa H, Egawa H, Inomata Y, Uemoto S, Asonuma K, Kiuchi T, Yamaoka Y, Tanaka K. Efficiency of pentoxifylline in donor pretreatment in rat liver transplantation. J Surg Res 1997; 72: 170-6.
29. Jacobsson J, Sunberg R, Rilo HS, Gasbarrini A, Starzl TE, Van Thiel DH. Protective effect of the lazaroid U74500A and lidoflazine on liver preservation with UW solution. Transp Int 1993; 6: 281-4.
30. 2-dependent mitochondrial swelling. Fundam Clin Pharmacol 1997; 11: 440-7.